CN101384591A - 抗病毒化合物 - Google Patents

抗病毒化合物 Download PDF

Info

Publication number
CN101384591A
CN101384591A CNA2006800531964A CN200680053196A CN101384591A CN 101384591 A CN101384591 A CN 101384591A CN A2006800531964 A CNA2006800531964 A CN A2006800531964A CN 200680053196 A CN200680053196 A CN 200680053196A CN 101384591 A CN101384591 A CN 101384591A
Authority
CN
China
Prior art keywords
alkyl
amino
group
carbonyl
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800531964A
Other languages
English (en)
Chinese (zh)
Inventor
D·A·贝特本纳
D·A·德格
C·J·马林
A·C·克吕格尔
岩崎仲彦
T·W·罗克维
C·S·库珀
D·D·安德森
P·L·唐纳
B·E·格林
D·J·肯普夫
D·刘
K·F·麦丹尼
D·L·马迪根
C·E·莫特
J·K·普拉特
J·P·尚利
M·D·图法诺
R·沃纳
R·张
A·莫拉
H·莫
T·J·皮洛-马蒂亚斯
S·Vl马斯
R·J·凯里克
W·何
L·卢
D·J·格拉姆波夫尼克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of CN101384591A publication Critical patent/CN101384591A/zh
Pending legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
CNA2006800531964A 2005-12-21 2006-12-20 抗病毒化合物 Pending CN101384591A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75247305P 2005-12-21 2005-12-21
US60/752,473 2005-12-21
US11/613,810 2006-12-20

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN2012101573389A Division CN102702193A (zh) 2005-12-21 2006-12-20 抗病毒化合物

Publications (1)

Publication Number Publication Date
CN101384591A true CN101384591A (zh) 2009-03-11

Family

ID=39830150

Family Applications (3)

Application Number Title Priority Date Filing Date
CNA2006800531964A Pending CN101384591A (zh) 2005-12-21 2006-12-20 抗病毒化合物
CNA2006800532079A Pending CN101384592A (zh) 2005-12-21 2006-12-20 抗病毒化合物
CNA200680053117XA Pending CN101443334A (zh) 2005-12-21 2006-12-20 抗病毒化合物

Family Applications After (2)

Application Number Title Priority Date Filing Date
CNA2006800532079A Pending CN101384592A (zh) 2005-12-21 2006-12-20 抗病毒化合物
CNA200680053117XA Pending CN101443334A (zh) 2005-12-21 2006-12-20 抗病毒化合物

Country Status (6)

Country Link
JP (1) JP2009521460A (ja)
CN (3) CN101384591A (ja)
CA (1) CA2633752A1 (ja)
ES (1) ES2348557T3 (ja)
RU (1) RU2441010C2 (ja)
ZA (2) ZA200805418B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102264737A (zh) * 2008-12-23 2011-11-30 雅培制药有限公司 抗病毒化合物
CN105924386A (zh) * 2009-03-25 2016-09-07 Abbvie 公司 抗病毒化合物和其用途
RU2644351C1 (ru) * 2016-11-15 2018-02-09 Федеральное государственное бюджетное учреждение науки Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук (ИОС УрО РАН) (3S)-4-[6-(Пурин-6-иламино)гексаноил]-3,4-дигидро-3-метил-7,8-дифтор-2Н-[1,4]бензоксазин и (3R)-4-[6-(Пурин-6-иламино)гексаноил]-3,4-дигидро-3-метил-7,8-дифтор-2Н-[1,4]бензоксазин, обладающие противовирусной активностью
EP3594205A1 (en) * 2018-07-09 2020-01-15 Abivax Phenyl-n-aryl derivatives for treating a rna virus infection
CN111518022A (zh) * 2019-02-02 2020-08-11 华东理工大学 具有杀虫活性的芳(杂)环醚类化合物及其制备方法和用途
CN113582842A (zh) * 2021-07-26 2021-11-02 苏州求索生物科技有限公司 一种乙醇酸苯甲酯的制备工艺

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003321472A (ja) * 2002-02-26 2003-11-11 Takeda Chem Ind Ltd Ｇｒｋ阻害剤
WO2004065392A1 (en) * 2003-01-24 2004-08-05 Smithkline Beecham Corporation Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands
WO2004087056A2 (en) * 2003-03-28 2004-10-14 Scios Inc. BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ
WO2005003100A2 (en) * 2003-07-03 2005-01-13 Myriad Genetics, Inc. 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
EP1675861B1 (en) * 2003-08-29 2015-12-23 Vernalis (R&D) Ltd. Pyrimidothiophene compounds
GB0326168D0 (en) * 2003-11-10 2003-12-17 Arrow Therapeutics Ltd Chemical compounds
EP1748991A1 (en) * 2004-04-28 2007-02-07 Arrow Therapeutics Limited Morpholinylanilinoquinazo- line derivatives for use as antiviral agents
BRPI0511834A (pt) * 2004-07-14 2008-01-08 Ptc Therapeutics Inc métodos por tratar hepatite c
GB0416168D0 (en) * 2004-07-20 2004-08-18 Vernalis Cambridge Ltd Pyrmidothiophene compounds
AP2007003923A0 (en) * 2004-09-30 2007-02-28 Tibotec Pharm Ltd Hcv inhibiting bi-cyclic pyrimidines
TW200716631A (en) * 2005-05-12 2007-05-01 Tibotec Pharm Ltd Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof
EP1928884B1 (en) * 2005-09-23 2010-01-13 Equispharm Co., Ltd. 5,6-dimethylthieno[2,3-di]pyrimidine derivatives, the preparation method thereof and the pharmaceutical composition comprising the same for anti-virus

Also Published As

Publication number Publication date
ES2348557T3 (es) 2010-12-09
RU2008129782A (ru) 2010-01-27
JP2009521460A (ja) 2009-06-04
RU2441010C2 (ru) 2012-01-27
CA2633752A1 (en) 2007-07-19
ZA200805418B (en) 2011-12-28
CN101443334A (zh) 2009-05-27
ZA201107667B (en) 2012-07-25
CN101384592A (zh) 2009-03-11

Similar Documents

Publication Publication Date Title
CN102702193A (zh) 抗病毒化合物
TWI399380B (zh) 抗病毒化合物
RU2467007C2 (ru) Производные [1,8]нафтиридина, полезные в качестве ингибиторов репликации вируса hcv
CN101248080B (zh) Vegf受体和hgf受体信号的抑制剂
DE60126997T2 (de) Stickstoff-enthaltende aromatische ringverbindungen zur behandlung von tumorerkrankungen
CN101155799A (zh) 嘧啶化合物和使用方法
CN101384591A (zh) 抗病毒化合物
NZ272258A (en) Substituted quinolone derivatives and pharmaceutical compositions
TWI392677B (zh) 抗病毒化合物、其製備方法及用途
JP2023545452A (ja) クリプトスポリジウム症の治療のための化合物及び組成物
BRPI0620440A2 (pt) compostos antivirais
MX2008008161A (en) Anti-viral compounds
MX2008008164A (en) Anti-viral compounds
UA81271C2 (en) 2-pyridone derivatives as inhibitors of neutrophile elastase, process for the preparation thereof and pharmaceutical composition based thereon
EP2345652A1 (en) Antiviral compounds

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20090311